SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-22-000027
Filing Date
2022-08-04
Accepted
2022-08-04 13:56:00
Documents
69
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20220630.htm   iXBRL 10-Q 2075784
2 EX-31.1 exhibit311-30jun22x10q.htm EX-31.1 8894
3 EX-31.2 exhibit312-30jun22x10q.htm EX-31.2 9137
4 EX-32.1 exhibit321-30jun22x10q.htm EX-32.1 5240
  Complete submission text file 0001048477-22-000027.txt   8210924

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20220630.xsd EX-101.SCH 44873
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20220630_cal.xml EX-101.CAL 73182
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20220630_def.xml EX-101.DEF 222902
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20220630_lab.xml EX-101.LAB 525845
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20220630_pre.xml EX-101.PRE 351783
63 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20220630_htm.xml XML 1739756
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 221135962
SIC: 2834 Pharmaceutical Preparations